Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Chongqing Brewery Surges on Profit Growth, Vaccine Plan

Chongqing Brewery Co., part owned by Carlsberg A/S, rose the most in almost three months in Shanghai trading after profit growth accelerated and it said it’ll continue investing to develop a hepatitis B vaccine.

The beer maker rose by the 10 percent daily limit to 20.92 yuan, the highest one-day percentage gain since May 29. China’s benchmark Shanghai Composite Index dropped 0.4 percent to the lowest level since March 2009.

Chongqing Brewery gained 3.9 percent on Aug. 17 after reporting an 11.6 percent increase in first-half profit the night before. That compared with a gain of 6.8 percent in the first quarter and a 57.6 percent drop for 2011. The beermaker, based in the western municipality of Chongqing, also said it plans to invest an additional 10 million yuan ($1.6 million) on a hepatitis B vaccine project started in 1998.

The shares fell 6.4 percent on May 31 after the company announced it was halting development of the vaccine. Chongqing Brewery generated more than 90 percent of revenue from beer and less than 1 percent from medicines last year, according to data compiled by Bloomberg.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.